CSPC Pharma Maintains Stable Share Capital in October 2026, Confirms Public Float Compliance

Bulletin Express11-02 19:01

For the month ended 31 October 2026, CSPC Pharmaceutical Group Limited reported no movement in its issued share capital. The number of ordinary shares in issue remained at 11.52 billion, with zero treasury shares outstanding or transferred.

Public Float The company confirmed compliance with the Hong Kong Main Board’s minimum public-float requirement of 25% of issued shares.

Share Option Position • 2015 Share Option Scheme: 1.30 million options remained outstanding. • 2026 Share Option Scheme: 1.15 billion options remained outstanding. No options were exercised during the month, resulting in: – No new shares issued. – No treasury shares transferred. – No proceeds raised from option exercises.

Other Equity Instruments The issuer reported no warrants, convertibles, or other equity-linked agreements in force during the period.

Governance Note The monthly return was signed by Company Secretary Lo Tai On and submitted to Hong Kong Exchanges and Clearing on 2 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment